Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
eNq1mF1v2jAUhu/5FVEudkcSykfTLaHaWLshtRqjoE27QSY5FLNgp/4Aul8/h8BKJ0dtDb5CxMl7Ts45fvwq0eVmmTkrYBxTErsNL3AdIAlNMbmP3fHouh66l91atEArdHDbuRd4jTPXSTLEeewWq94UEOHez9ubz6CeB+Z2a05EpwtIxLP7pMCZ9xXx+S3Ki3ucaEVx6ixBzGkau7kU26tOxAVTWXTXlP3mOUog8ndXDlcXk9bh9cgvxF6hKjmwG0TutaJAjDQTyRgQ0UMC7il7rMi3aaSN+RA4lSyBARLzAaMrnEKqDTFDGQejILN1egdslYEogmjF/UWy5EbiaIE2Q3jo65P+qFZ7YiPqQb1xHgYXYat53gnbHaNQ7KBU+i6ol/CTSSMIzjphywfiq8kkKUb17S9SyoZdGlAmUGapP5j3no+YpTgMHl6cgxTzPEOP3oLnpqVCrCg0MAUCey9SvMGIKTRlqmb/6ROZZf4bsx7vwGEp44JLPSqJqODH9dC0ED1KBGyqO2qGPLHZzSIGfjrZP5TocT+Q0wwnpnBT+JHAxXjYr2abHSx8QhzGzB4XfmCS0jU/PW8O+2sp+3yLTK1oztLG5Owi7DTabePt9EsNU8WpcyUZzcFXJML8GMD0yYweixY1n3qp/XRaGMytC6IJyqDCB9UNeaMmcm/brM28vf1ULmhFv1yNTAfluwT2eLf9q5XGafyvxWYwtkF4NZYvJV5u4DifNIN2eNFsvUPL/MPeYMeGZroUteKlJdPTZi5Ezt/7/nq99uaI1zlS9fRm7DXnwqW2CKcohILwU1/tGX8r9qC0SyWALaU+LU/WtzXUdAu/ZCCONcW753fmWxtDMAlH9KKkvTUm969Oj/knR2wt7cEz2NgLs3WvSGBKbHkpOdUqHnewqL6Sa6YA8W02wxUfYirnMvLLj0DdWuQXH4C6tb9Qtw9U
pVN4KK7GybMzqs5u
